The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention [0.03%]
脂蛋白(a)在早发性心血管疾病中的作用：预防策略蓄势待发
Maya S Safarova,Laurence Sperling,Anurag Mehta et al.
Maya S Safarova et al.
Elevated Lp(a) is an independent, causal, genetic cardiovascular disease risk factor that is associated with the progression of high-risk coronary plaques. Risk of atherosclerotic cardiovascular disease (ASCVD)-related conditions, which are...
From Risk Stratification to Individualized Cardiac Rehabilitation: Expanding the Role of Physical Performance Assessment After Myocardial Infarction [0.03%]
从风险分层到个体化心脏康复：心肌梗死后物理表现评估角色的扩展
Akihiro Ogawa,Kanzaki Shinya,Shimizu Kazuhiro
Akihiro Ogawa
Ilham Benzidia,Victor Aboyans
Ilham Benzidia
Astefanos Al-Dalakta,Chadi Tabaja,Luke J Laffin et al.
Astefanos Al-Dalakta et al.
Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank [0.03%]
英国生物样本库中高密度脂蛋白胆固醇与载脂蛋白B的互作以及动脉粥样化心血管疾病的发生风险
Allan Sniderman,Karol Pencina,George Thanassoulis et al.
Allan Sniderman et al.
Background: Apolipoprotein B (apoB) is the most accurate causal lipid factor associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). While high HDL cholesterol has been considered protective, HDL...
Cardiovascular-Kidney-Metabolic Syndrome and Long-Term Risk of Cardiovascular Disease and all-cause Mortality [0.03%]
心血管-肾脏-代谢综合征与长期心血管疾病和全因死亡率风险的关系
Noushin Sadat Ahanchi,Roxane de la Harpe,Benoît Delabays et al.
Noushin Sadat Ahanchi et al.
Aims: To examine the associations between cardiovascular-kidney-metabolic syndrome (CKM) stages and the risk of cardiovascular disease (CVD), including atherosclerotic CVD (ASCVD), and all-cause mortality (ACM), stratifie...
Preventing cardiovascular disease within the built and living environment: An Expert Opinion [0.03%]
关于从建筑和生活环境预防心血管疾病的专家意见
Christina Chrysohoou,Erik Timmermans,Buket Akinci et al.
Christina Chrysohoou et al.
Cardiovascular (CV) health is influenced not only by biological factors but also by the environments in which people live. The environment comprises interconnected built, living, and social domains that shape health behaviours, psychosocial...
"Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history" - authors' reply [0.03%]
"Lp(a)的药理学风险分层：糖尿病状况可能细化了ASCVD病史之外的剩余心血管风险（作者回复）"
Sam-Lennart Oftadeh,Dirk Müller-Wieland,Marlo Verket
Sam-Lennart Oftadeh
Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries [0.03%]
冠心病患者的高血压知晓率、治疗及控制情况：来自27个国家EUROASPIRE V调查的结果
Anna Marzà Florensa,Piotr Jankowski,Ilonca Vaartjes et al.
Anna Marzà Florensa et al.
Aims: Hypertension is a highly common cardiovascular risk factor, and a large proportion of patients with coronary heart disease (CHD) have uncontrolled hypertension. We report on the distribution and determinants of hype...
Correction to: Plasma soluble TREM-1 and risk of cardiovascular disease in the population. Results from the Paris Prospective Study III and the CoLaus|PsyCoLaus [0.03%]
对人群血浆可溶性TREM-1与心血管病风险关联的研究结果：巴黎前瞻性研究Ⅲ和科拉vs| Psy科拉vs子队列中的发现的更正
Published Erratum
European journal of preventive cardiology. 2026 Jul 29:zwag388. DOI:10.1093/eurjpc/zwag388 2026